| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/04/2002 | US20020086345 Methods and compositions for the visualization of cellular organelles using tetrazolium salts |
| 07/04/2002 | US20020086332 Method of reducing bacterial proliferation |
| 07/04/2002 | US20020086315 Method of determining a chemotherapeutic regimen based on ERCC1 expression |
| 07/04/2002 | US20020086308 Ribosome crystaline structure; for use in killing or prevention of propagation of target organism |
| 07/04/2002 | US20020086067 Catechins and green tea extract for the treatment of amyloidosis in alzheimer's disease and other amyloidoses |
| 07/04/2002 | US20020086065 Methods and compositions for the benefit of those suffering from polycystic ovary syndrome with chromium complexes |
| 07/04/2002 | US20020086061 Forming a drug containing core by compressing comprising granulated microparticles of felodipine and cyclodextrin, carrier comprising cyclodextrin particles, a water-insoluble alkaline component and a swellable polymer |
| 07/04/2002 | US20020086059 Dissolving solid material in dimethyl ether under a pressure and heating; reducing pressure on solution to precipitate the solid material as pulverous formulation and to expand dimethyl ether into a gas, separating |
| 07/04/2002 | US20020086057 For therapy of urinary incontinence |
| 07/04/2002 | US20020086056 Tablet containing a coated core |
| 07/04/2002 | US20020086053 As antidepressant |
| 07/04/2002 | US20020086052 Rapidly disintegrating methylcellulose tablets |
| 07/04/2002 | US20020086049 Apoptosis-mimicking synthetic entities and use thereof in medical treatment |
| 07/04/2002 | US20020086048 Design and application method for enhanced oral assimilation through the oral mucosa and/or intestinal membranes, of liquids containing nutrients, nutraceuticals or drugs, which are encapsulated in natural and/or synthetic liposomal vesicles |
| 07/04/2002 | US20020086041 Hydroxydecenoic acid compounds for promoting desquamation/epidermal renewal of the skin and/or combating skin aging |
| 07/04/2002 | US20020086038 Long-lasting styling mousse |
| 07/04/2002 | US20020086032 Administering immunogenic dose of attenuated bacteria comprising altered DNA adenine methylase (Dam) activity relative to a wild-type bacteria for generating immune response and produce antibodies |
| 07/04/2002 | US20020086029 For use in inhibiting gastric acid secretion; therapy of gastric acid related diseases |
| 07/04/2002 | US20020086020 Method for improving the half-life of soluble viral receptors on mucosal membranes |
| 07/04/2002 | US20020086016 Diagnostic methods based upon a particular genotype in the Tumor Necrosis Factor (TNF alpha ) gene |
| 07/04/2002 | US20020086015 Compositions and methods for promoting nerve regeneration |
| 07/04/2002 | US20020086013 Administering an agent that inhibits a component of the VEGF signal transduction pathway; agent decreases a connective tissue growth factor (CTGF) activity in the tissue of the subject. |
| 07/04/2002 | US20020086011 Administering an effective amount of an OX-2 protein or a nucleic acid encoding an OX-2 protein; use to suppress an immune response and to prevent or treat autoimmune disease, especially arthritis. |
| 07/04/2002 | US20020085997 Tumor cells at least some of which contain at least one MHC-I-haplotype of the patient on the cell surface, and which are charged with one or more peptides binding to the MHC-I molecule |
| 07/04/2002 | US20020085995 In vivo induction for enhanced function of isolated hepatocytes |
| 07/04/2002 | US20020085978 Containing a propellant, a cosolvent, and a radical quencher. |
| 07/04/2002 | US20020085615 Differential scanning calorimeter |
| 07/04/2002 | US20020084221 Method for precipitating red blood cells |
| 07/04/2002 | DE10150312A1 New 2-(m-amino-phenylimino)-imidazolidine derivatives, are potent and selective alpha-1L agonists useful for treating bladder disorders, especially urinary incontinence |
| 07/04/2002 | DE10130128A1 Treatment of herpes zoster infections or post-herpetic neuralgia by once-daily oral administration of brivudine, giving superior results to higher dose and more frequent administration of acyclovir |
| 07/04/2002 | DE10065710A1 Arzneimittel enthaltend ein Polyamin als Wirksubstanz A medicament comprising a polyamine as the active substance |
| 07/04/2002 | DE10065482A1 New heavier halogen atom substituted squarane dyes, used as photosensitizer in photodynamic therapeutical applications, fluorescent detector of tumors and sensitizer in water sterilization |
| 07/04/2002 | DE10064994A1 Sulfamidothienopyrimidine Sulfamidothienopyrimidine |
| 07/04/2002 | DE10064993A1 Drug formulation useful e.g. for treating angina or hypertension contains pyrazolo (4,3-d) pyrimidine derivative phosphodiesterase V inhibitor and antithrombotic agent, calcium antagonist or prostaglandin |
| 07/04/2002 | DE10064453A1 Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen Use of a dopaminergic agent for the treatment of dopaminergic treatable diseases |
| 07/04/2002 | DE10063435A1 Chinazolinderviate,diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung Chinazolinderviate, medicaments containing these compounds, their use and process for their preparation |
| 07/04/2002 | DE10063294A1 New N-(heterocyclyl-alkyl)-fused norbornylamine derivatives, are NHE3 inhibitors useful e.g. for treating respiratory disorders, renal failure, intestinal dysfunction, lipid metabolism disorders or proliferative diseases |
| 07/04/2002 | DE10059144A1 Modulation der Transkription pro-inflammatorischer Genprodukte Modulating the transcription of pro-inflammatory gene products |
| 07/04/2002 | DE10044649A1 Substituierte 4-Phenyl-1-(1-phenyl-cyclohexyl)-1,2,3,6-tetrahydropyridine Substituted 4-phenyl-1- (1-phenylcyclohexyl) -1,2,3,6-tetrahydropyridines |
| 07/04/2002 | CA2782510A1 Polypeptides |
| 07/04/2002 | CA2626317A1 Crystalline forms of atorvastatin |
| 07/04/2002 | CA2623600A1 Crystalline forms of atorvastatin |
| 07/04/2002 | CA2623599A1 Crystalline forms of atorvastatin |
| 07/04/2002 | CA2622727A1 Crystalline forms of atorvastatin |
| 07/04/2002 | CA2622697A1 Crystalline forms of atorvastatin |
| 07/04/2002 | CA2622477A1 Crystalline forms of atorvastatin |
| 07/04/2002 | CA2441896A1 Quinuclidine carbamate derivatives and their use as m3 antagonists |
| 07/04/2002 | CA2437209A1 Remedies for hepatitis c |
| 07/04/2002 | CA2436739A1 Combination agent |
| 07/04/2002 | CA2433861A1 Controlled release of anti-arrhythmic agents from a biodegradable polyethylene oxide hydrogel for local application to the heart |
| 07/04/2002 | CA2433520A1 Novel compounds and compositions as cathepsin inhibitors |
| 07/04/2002 | CA2433264A1 Agent for treating and/or preventing diseases due to retinal ischemia |
| 07/04/2002 | CA2433259A1 Azole compounds as anti-fungals agents |
| 07/04/2002 | CA2433220A1 Novel purine derivatives, preparation method and use as medicines |
| 07/04/2002 | CA2433138A1 Heterocyclic compounds having antibacterial activity, process for their preparation and pharmaceutical compositions containing them |
| 07/04/2002 | CA2433100A1 Indole derivatives as ligands of thyroid receptors |
| 07/04/2002 | CA2432896A1 Thermoformable solid pharmaceutical composition for controlled release of perindopril |
| 07/04/2002 | CA2432661A1 Heterocyclylalkylindole or -azaindole compounds as 5-hydroxytryptamine-6 ligands |
| 07/04/2002 | CA2432654A1 Heterocyclindazole and azaindazole compounds as 5-hydroxytryptamine-6 ligands |
| 07/04/2002 | CA2432645A1 Thermoformable solid pharmaceutical composition for controlled release of ivabradine |
| 07/04/2002 | CA2432644A1 Pharmaceutical composition comprising aspirintm and cs-747 |
| 07/04/2002 | CA2432570A1 New clinical treatment |
| 07/04/2002 | CA2432543A1 Combination drugs |
| 07/04/2002 | CA2432536A1 Angiogenesis inhibitor |
| 07/04/2002 | CA2432527A1 Medicinal compositions for oral use |
| 07/04/2002 | CA2432523A1 Compositions of stable t3 and methods of use thereof |
| 07/04/2002 | CA2432518A1 Treatment of inoperable tumors by stereotactic injection of microspheres |
| 07/04/2002 | CA2432473A1 3-indoline derivatives useful in the treatment of psychiatric and neurologic disorders |
| 07/04/2002 | CA2432008A1 Carbazole derivatives and their use as neuropeptide y5 receptor ligands |
| 07/04/2002 | CA2431953A1 Piperidine mch antagonists and their use in the treatment of obesity |
| 07/04/2002 | CA2431906A1 Process to improve stability of a pharmaceutical composition |
| 07/04/2002 | CA2431883A1 Choline pyruvate, method for the production thereof, formulations containing choline pyruvate and the use thereof |
| 07/04/2002 | CA2431835A1 Induction of tolerance |
| 07/04/2002 | CA2431471A1 Tetrahydropyridine derivatives, their preparation and their use as cell proliferation inhibitors |
| 07/04/2002 | CA2431415A1 Divalproex sodium dosage forms and a process for their production |
| 07/04/2002 | CA2431375A1 Solid dosage forms of divalproex sodium |
| 07/04/2002 | CA2430930A1 Helicobacter proteins, nucleic acids and uses thereof |
| 07/04/2002 | CA2430691A1 Immunomodulatory polynucleotides and methods of using the same |
| 07/04/2002 | CA2429773A1 Aerogel powder comprising therapeutic agents |
| 07/04/2002 | CA2429709A1 Motilide compounds |
| 07/03/2002 | EP1219709A1 Nucleozymes |
| 07/03/2002 | EP1219708A1 Modulate aptamer and method for detecting target protein by using the same |
| 07/03/2002 | EP1219638A2 G-protein coupled receptors having homology to the P2Y purinoreceptor 1 (P2Y1) |
| 07/03/2002 | EP1219632A1 Steroids, their preparation, pharmaceutical compositions thereof and uses of the compounds |
| 07/03/2002 | EP1219630A1 Immunopotentiating compositions |
| 07/03/2002 | EP1219624A1 Remedies for neuropathic pain and model animals of neuropathic pain |
| 07/03/2002 | EP1219623A1 New esters derived from substituted phenyl-cyclohexyl compounds |
| 07/03/2002 | EP1219622A2 Pharmaceutical compositions for CNS and other disorders |
| 07/03/2002 | EP1219614A1 Benzene sulfonamides as PDE-V inhibitors for the use against erectile dysfunction |
| 07/03/2002 | EP1219612A1 2-imino-1,3-thiazine derivatives |
| 07/03/2002 | EP1219609A1 Aromatic nitrogenous six-membered ring compounds |
| 07/03/2002 | EP1219606A1 Tricyclic compounds bearing acyloxymethoxycarbonyl pendants |
| 07/03/2002 | EP1219604A1 Method for improving the solubility of tricyclic amino alcohol derivatives |
| 07/03/2002 | EP1219594A1 New esters derived from substituted phenyl-cyclohexyl compounds |
| 07/03/2002 | EP1219306A1 Compositions comprising cyclodextrins and NO- releasing drugs |
| 07/03/2002 | EP1219304A2 Stable parenteral solution containing diclofenac salts, their preparation and use therof |
| 07/03/2002 | EP1219302A1 Trapping agent for blood carbonyl compounds |
| 07/03/2002 | EP1219297A1 Antiobestic agents |
| 07/03/2002 | EP1219296A1 Sebum production inhibitors |
| 07/03/2002 | EP1219295A1 Controlled release formulation of valproate |